ÕÒÂÛÎÄÍø > ҽҩѧÂÛÎÄ > ҩѧÂÛÎÄ >

ͨ¹ý·Ö×ÓÄڵĿÁª·´Ó¦ºÏ³ÉʮԪ»·×´Ï©¶þȲ(1)

              ×÷ÕߣºÔ¬½¨Ó ¹ù»ÛÔª Àî׿ÈÙ ÕÅÖÂÆ½

¡¾ÕªÒª¡¿  ¡¡¡¡ ÒÔ˳ʽ1£¬2-¶þÂÈÒÒϩΪԭÁÏ£¬¾­Áù²½·´Ó¦£¬µÃµ½Óë·¼»·æéÁ¬µÄ¹²éî»·×´Ï©¶þȲ£¬±¾ÎÄÊ×´ÎÒÔ·Ö×ÓÄڵĿÁª·´Ó¦×÷Ϊ»·ºÏ·´Ó¦À´ºÏ³É»·×´Ï©¶þȲ¡£

¡¾¹Ø¼ü´Ê¡¿  »·×´Ï©¶þȲ

¡¡¡¡ Studies on total synthesis of enediyne antitumor antibiotics V.Synthesis of cyclodeca©´1£¬5©´diyne©´3©´ene skeleton via intramolecular cross©´coupling

    Yuan Jian-yong£¬ Guo Hui-yuan£¬ Li Zhuo-rong and Zhang Zhi-ping £¨Institute of Medicinal Biotechnology£¬Peking Union medical College and Chinese Academy of Medical Sciences£¬ Beijing100050£©

    ABSTRACT During the course of synthesis a cyclodeca-1£¬5-diyne-3-ene skeleton was synthesized.Cyclization of aromatic bromide containing terminal alkyne was achieved by using an intramolecular cross-coupling reaction catalyzed by Pd£¨0£©and Cu£¨I£©.

    KEY WORDS Enediyne; Antitumor antibiotics; Cross-coupling; Synthesis

     Ï©¶þȲÀ࿹ÉúËØÊǽüÄê·¢ÏֵĿ¹Ö×Áö»îÐÔÎïÖÊ£Û1¡«4£Ý ¡£¸ÃÀ࿹ÉúËØµÄ×÷ÓûúÖÆÊÇÓÉÏ©¶þȲµ¥Ôª¾­¹ýBergman·¼»·»¯£¨I¡úII£©£Û5£Ý »òMyers·¼»·»¯£¨III¡úIV£©£Û6£Ý £¨Fig.1£©£¬Ðγɷ¼¶þ×ÔÓÉ»ù£¬×ÔÓÉ»ùÔÙ´ÓÖ×Áöϸ°ûDNAÌÇÁ×Ö¬¹Ç¼ÜÉ϶áÈ¡ÇâÔ­×Ó£¬ÒýÆðÖ×Áöϸ°ûDNA¶ÏÁÑ£¬´Ó¶øÉ±ËÀÖ×Áöϸ°û¡£

    ¼øÓÚ¸ÃÀ࿹ÉúËØ¶ÀÌØµÄ·Ö×ӽṹ£¬ÐÂÓ±µÄ×÷ÓûúÖÆ£¬²¢ÇÒ¾ßÓкÜÇ¿µÄ¿¹Ö×Áö×÷Ó㬽üÄêÀ´ÒÑÒýÆðÈËÃǵĹØ×¢¡£ÕâЩ¿¹ÉúËØ£¨»òÆä·¢É«ÍÅ£©µÄ»îÐÔ²¿Î»¾ùÀ´Ô´ÓÚº¬Ï©¶þȲ»òÏ©¶þȲǰÌåµÄ»·×´½á¹¹¡£¿¼²ì´ËÀ໯ºÏÎïµÄ½á¹¹£¬¿É¿´³öÆäºËÐIJ¿·ÖΪһ¸öÔØÌ廷ϵºÍÓëÖ®æéÁ¬µÄ¹²éîÏ©¶þȲ¡£¹²éîϩȲµÄºÏ³É£¬³£Óñ´úÏ©Óë¶ËȲµÄżÁª·´Ó¦¡£ÎÄÏ×£Û7£ÝÏȺϳÉÊ®ÎåÔª»·ÄÚõ¥£¬ÔÙÀûÓ÷Ö×ÓÄÚµÄDiels-Alder·´Ó¦À´ºÏ³É»·×´Ï©¶þȲ£¬ÎÄÏ×£Û8£ÝÀûÓÃäå´úÏ©Óë»î»¯Á˵ÄÈý¶¡»ùÎýȲ·´Ó¦¡£ÎÒÃÇÔø²Î¿¼ ÎÄÏ×£Û9£ÝÊÔͼÓÃäå´úÏ©Óë¶ËȲµÄżÁª·´Ó¦À´ºÏ³É²¢Áª·¼»·µÄʮԪ»·×´Ï©¶þȲµ¥ÔªÑÜÉúÎ½á¹ûδÄܳɹ¦£Û10£Ý ¡£±¾ÎÄÏȽ«Ï©¶þȲ½á¹¹Æ¬¶ÏÒýÈëäå´ú±½µÄÁÚλ£¬È»ºóÔÚîÙ´ß»¯¼ÁµÄ´æÔÚÏ£¬Í¨¹ý·Ö×ÓÄڵĿÁª·´Ó¦£¬³É¹¦µØºÏ³ÉÁËʮԪ»·×´Ï©¶þȲµ¥ÔªÑÜÉúÎΪϩ¶þȲÀ࿹Ö×Áö¿¹ÉúËØµÄÈ«ºÏ³Éµì¶¨Á˳õ²½»ù´¡¡£

    ÔÚîÙ´ß»¯¼Á´ß»¯Ï£¬Ë³Ê½1£¬2-¶þÂÈÒÒÏ©£¨1£©ÓëȲ±û»ùËÄÇâßÁà«»ùÃÑżÁªµÃ¹²éîϩȲ£¨2£©£¬£¨2£©ÔÙÓëÈý¼×¹è»ùÒÒȲżÁªµÃ˳ʽϩ¶þȲ£¨3£©£¬¶Ô£¨3£©½øÐÐÈ¥±£»¤»ù»¯ÏȺóµÃµ½£¨4£©ºÍ£¨5£©¡£¶Ô£¨5£©µÄôÇ»ù½øÐÐäå´ú£¬µÃäå´úϩȲ£¨6£©£¬£¨6£©µÄ¸ñÊÏÊÔ¼ÁÓëäå´ú±½¼×È©·´Ó¦£¬µÃÓë±½»·æéÁ¬µÄ¿ªÁ´Ï©¶þȲ£¨7£©£¬£¨7£©·¢Éú·Ö×ÓÄڵĿÁª·´Ó¦µÃÄ¿±ê»¯ºÏÎ8£©£¨Fig.2£©¡£ ʵÑ鲿·Ö ÇâÆ×ÓÃMercury-300ºË´Å¹²ÕñÒDzⶨ£¬TMSΪÄڱ꣬ÖÊÆ×ÓÃAutoSpec Ultima-TofÖÊÆ×ÒDzⶨ¡£2-äå±½¼×È©´ÓAldrich¹«Ë¾¹ºµÃ¡££¨Z£©-1-ÂÈ-3-Ȳ-5-ËÄÇâßÁà«Ñõ»ù-ÎìÏ©-1£¨2£©  1£¬2-¶þÂÈÒÒÏ©£¨25g£¬0.26mol£©£¬¼ÓÈëÕý¶¡°·£¨50ml£©¡¢ËÄ£¨Èý±½»ù좣©ºÏîÙ£¨14.90g£¬0.013mol£©ºÍµâ»¯ÑÇÍ­£¨2.45g£¬0.013mol£©£¬ÊÒÎÂÏÂë²Æø±£»¤£¬ÂýÂýµÎ¼Ó±ûȲ´¼ËÄÇâßÁà«ÃÑ£¨43g£¬0.31mol£©ÈÜÓÚÕý¶¡°·£¨50ml£©ÖеÄÈÜÒº£¬¿ØÖƵμÓËÙ¶È£¬Ê¹·´Ó¦Ìåϵ±£³ÖÔÚ30¡æÒÔÏ£¬µÎ¼ÓÍê±Ïºó£¬ÔÙÓÚÊÒνÁ°è2h£¬TLC¼à²â·´Ó¦ÍêÈ«¡£¼õѹÕôÈ¥¶àÓàµÄÕý¶¡°·£¬¼ÓÈëË®£¨100ml£©ºÍÒÒÃÑ£¨4¡Á100ml£©ÝÍÈ¡£¬ÝÍȡҺÓñ¥ºÍʳÑÎË®£¨2¡Á100ml£©Ï´µÓ¡£ÎÞË®ÁòËáþ¸ÉÔï¡£¼õѹÕôÈ¥ÈܼÁ£¬²ÐÎï¾­¿ìËٹ轺Öù²ãÎö£¨Ê¯ÓÍÃѺÍÒÒËáÒÒõ¥ÌݶÈÏ´ÍÑ£©£¬µÃ»ÆÉ«ÓÍ×´²úÎ2£©£¨33.08g£¬²úÂÊ64%£©¡£²¨Æ×Êý¾Ý¼ûTab.1£¨ÏÂͬ£©¡£

    £¨Z£©-1-Èý¼×¹è»ù-1£¬5-¶þȲ-7-ËÄÇâßÁà«Ñõ»ù-¸ýÏ©-3£¨3£©

    »¯ºÏÎï2£¨2.0g£¬0.01mol£©¼ÓÈëÕý¶¡°·£¨20ml£©¡¢ËÄ£¨Èý±½»ù좣©ºÏîÙ£¨0.58g£¬0.005mol£©¡¢µâ»¯ÑÇÍ­£¨0.1g£¬0.005mol£©ºÍÈý¼×¹è»ùÒÒȲ£¨0.98g£¬0.01mol£©ÈÜÓÚÈýÒÒ°·£¨10ml£©µÄÈÜÒº£¬ë²Æø±£»¤Ï£¬ÊÒνÁ°è1.5h£¬TLC¼à²â·´Ó¦Íê±Ï¡£¼ÓÈëµ½±¥ºÍÂÈ»¯ï§ÈÜÒº£¨30ml£©ÖУ¬ÒÒÃÑ£¨4¡Á50ml£©ÝÍÈ¡£¬ºÏ²¢ÝÍȡҺ£¬Óñ¥ºÍʳÑÎË®£¨2¡Á50ml£©Ï´µÓ£¬ÎÞË®ÁòËáþ¸ÉÔï¡£¼õѹÕôÈ¥ÈܼÁ£¬²ÐÎï¾­¿ìËٹ轺Öù²ãÎö£¨Ê¯ÓÍÃѺÍÒÒËáÒÒõ¥ÌݶÈÏ´ÍÑ£©£¬µÃÎÞÉ«ÓÍ×´²úÎ3£©£¨1.75g£¬²úÂÊ67%£©¡£

¹²2Ò³: 1 [2] ÏÂÒ»Ò³


Õæ¾úϸ°û±ÚÒÖÖÆ¼ÁH6794©´AµÄ½á¹¹¼ø¶¨ºÍ¿¹¾ú»îÐÔµÄÑо¿
ÆøÏàÉ«Æ×·¨²â¶¨Í·æßßÁë¿ÖÐN©´¼×»ùßÁ¿©ÍéÔÓÖʺ¬Á¿
¹¤É̹ÜÀí | ¹¤¿ÆÂÛÎÄ | ²ÆÎñ¹ÜÀí | ¹ÜÀíѧ | ¹«¹²¹ÜÀí | ²ÆÕþ˰ÊÕ | ֤ȯ½ðÈÚ | »á¼ÆÉó¼Æ | ¼ÆËã»ú | ·¨ÂÉÂÛÎÄ | ҽҩѧ | ººÓïÑÔÎÄѧ
Éç»áÂÛÎÄ | ¹¤¿ÆÂÛÎÄ | Àí¿ÆÂÛÎÄ | ÎÄ»¯ÂÛÎÄ | ÒÕÊõÂÛÎÄ | ÎÄѧÂÛÎÄ | ÕÜѧÂÛÎÄ | ÕþÖÎÂÛÎÄ | Ó¢ÓïÂÛÎÄ | д×÷Ö¸µ¼ | ¼ÆËã»úÓ¦ÓÃ
www.zlunwen.com ÕÒÂÛÎÄÍø ® °æÈ¨ËùÓÐ ÍøÕ¾µØÍ¼